AU2001284496A1 - Insulin secretion controlling agents - Google Patents

Insulin secretion controlling agents

Info

Publication number
AU2001284496A1
AU2001284496A1 AU2001284496A AU8449601A AU2001284496A1 AU 2001284496 A1 AU2001284496 A1 AU 2001284496A1 AU 2001284496 A AU2001284496 A AU 2001284496A AU 8449601 A AU8449601 A AU 8449601A AU 2001284496 A1 AU2001284496 A1 AU 2001284496A1
Authority
AU
Australia
Prior art keywords
insulin secretion
controlling agents
secretion controlling
agents
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284496A
Inventor
Kazuhito Rokutan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001284496A1 publication Critical patent/AU2001284496A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001284496A 2000-09-11 2001-09-10 Insulin secretion controlling agents Abandoned AU2001284496A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000280153 2000-09-11
JP2000-280153 2000-09-11
PCT/JP2001/007816 WO2002022170A1 (en) 2000-09-11 2001-09-10 Insulin secretion controlling agents

Publications (1)

Publication Number Publication Date
AU2001284496A1 true AU2001284496A1 (en) 2002-03-26

Family

ID=18765048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284496A Abandoned AU2001284496A1 (en) 2000-09-11 2001-09-10 Insulin secretion controlling agents

Country Status (2)

Country Link
AU (1) AU2001284496A1 (en)
WO (1) WO2002022170A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4436834B2 (en) * 2003-06-21 2010-03-24 エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション Composition for screening antihypertensive agent containing mammalian TCTP gene or protein product thereof, and method for screening antihypertensive agent using the composition
JP4362478B2 (en) * 2003-07-14 2009-11-11 独立行政法人科学技術振興機構 Method for determining endometriosis-related diseases
AU2004255685A1 (en) * 2003-07-14 2005-01-20 Periodock Co., Ltd. Method of diagnosing disease relating to endometriosis
WO2017214942A1 (en) * 2016-06-16 2017-12-21 毛侃琅 Lentiviral expression vector for improving expression of tctp gene, and applications thereof

Also Published As

Publication number Publication date
WO2002022170A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2001296981A1 (en) Chair control
AU2001268275A1 (en) Switched uniformity control
AU2002246336A1 (en) Benzamidine derivative
AU2001252135A1 (en) Therapeutic agents
AU9517301A (en) Implant
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2002246515A1 (en) Medicated tattoos
AU2002222853A1 (en) Therapeutic compounds
AU2002342653A1 (en) Modified growth hormone
AU2001263841A1 (en) Implant
AU2001274548A1 (en) Syringe
AU2001278755A1 (en) Injections
AU2002359919A1 (en) Syringe
AU2002361092A1 (en) Syringe
AU2001285258A1 (en) Analog control
AU2001276511A1 (en) Respirators
AU2001275904A1 (en) Dust control
AU2001238125A1 (en) Hydristor control means
AU2001273903A1 (en) Therapeutic agents
AU2001284496A1 (en) Insulin secretion controlling agents
AU2001260236A1 (en) Restricted use syringe
AU2001287621A1 (en) Controlling device
AU2002349142A1 (en) Syringe
AU2001256535A1 (en) Control circuitry
AUPR102400A0 (en) Filter control